Background A few studies have assessed the epidemiological impact and the cost-
effectiveness of COVID-19 vaccines in settings where most of the population had been …

The African Union Bureau of Heads of State and Government endorsed the COVID-19
Vaccine Development and Access Strategy to vaccinate at least 60% of each country's …

Low-and middle-income countries are implementing COVID-19 vaccination strategies in
light of varying vaccine efficacies and costs, supply shortages, and resource constraints …

Background The COVID-19 vaccine supply shortage in 2021 constrained roll-out efforts in
Africa while populations experienced waves of epidemics. As supply improves, a key …

Introduction To end the COVID-19 pandemic, the WHO set a goal in 2021 to fully vaccinate
70% of the global population by mid-2022. We projected the COVID-19 vaccination …

Background Multiple Coronavirus Disease 2019 (COVID-19) vaccines appear to be safe
and efficacious, but only high-income countries have the resources to procure sufficient …

Background The first COVID-19 vaccine outside a clinical trial setting was administered on
Dec 8, 2020. To ensure global vaccine equity, vaccine targets were set by the COVID-19 …

Disparities in COVID-19 vaccine coverage across the globe have uncovered inequities in
global healthcare. While more than half of the population of the developed countries have …

Methods we reviewed and identified the key lessons and challenges documented in the
reports from intra-action review of COVID vaccine roll out in 22 African countries. Results all …

SELECTING VACCINES: THE LONG TERM As we have already seen, there is a temptation
for governments to invest most of their available resources in the vaccines exhibiting the …